Taigen Biopharmaceuticals Holdings Ltd (4157) — Cash Flow-to-Debt Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Cash Flow-to-Debt Ratio of -0.52x as of September 2025, meaning its operating cash flow of NT$-62.73 Million could theoretically repay -1% of its total liabilities (NT$120.70 Million) in one year. See cash generation quality of Taigen Biopharmaceuticals Holdings Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Taigen Biopharmaceuticals Holdings Ltd Cash Flow-to-Debt Ratio (2010–2024)
Historical debt coverage capacity for Taigen Biopharmaceuticals Holdings Ltd across 15 annual periods. Also explore 4157 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Taigen Biopharmaceuticals Holdings Ltd (2010–2024)
Year-by-year debt coverage analysis for Taigen Biopharmaceuticals Holdings Ltd. For market capitalisation and broader financial context, see 4157 market cap.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.88x | NT$-173.09 Million | NT$91.96 Million | ▼ -1106.8% |
| 2023 | 0.19x | NT$20.74 Million | NT$110.94 Million | ▲ +167.7% |
| 2022 | -0.28x | NT$-21.27 Million | NT$76.98 Million | ▼ -106.1% |
| 2021 | 4.52x | NT$629.07 Million | NT$139.11 Million | ▲ +313.4% |
| 2020 | -2.12x | NT$-242.10 Million | NT$114.26 Million | ▲ +19.0% |
| 2019 | -2.62x | NT$-342.52 Million | NT$130.92 Million | ▲ +3.2% |
| 2018 | -2.70x | NT$-254.93 Million | NT$94.36 Million | ▲ +1.1% |
| 2017 | -2.73x | NT$-266.93 Million | NT$97.71 Million | ▼ -164.2% |
| 2016 | -1.03x | NT$-152.83 Million | NT$147.82 Million | ▲ +67.9% |
| 2015 | -3.22x | NT$-592.56 Million | NT$183.86 Million | ▼ -46.8% |
| 2014 | -2.19x | NT$-540.03 Million | NT$246.05 Million | ▼ -59.3% |
| 2013 | -1.38x | NT$-458.46 Million | NT$332.71 Million | ▼ -252.0% |
| 2012 | -0.39x | NT$-141.36 Million | NT$361.15 Million | ▲ +90.0% |
| 2011 | -3.90x | NT$-379.23 Million | NT$97.31 Million | ▼ -10617.6% |
| 2010 | -0.04x | NT$-196.43 Million | NT$5.40 Billion | — |